🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
We will study the total gastrointestinal transit time (GITT), gastric empty...
Status
Completed
Location
Analfysiologisk afsnit, Aarhus University Hospital, Tage Hansensgade, entrance 11A
Start Date
2008-09
Trial ID
NCT00789841
Treatments Being Tested
The goal of this clinical trial\] is to to Assess the Food Effect on the Re...
Status
Completed
Location
Zibo Central Hospital
Start Date
2026-06-25
Trial ID
NCT07663318
This study is for patients with neuroblastoma or a neuroendocrine tumor who...
Status
Withdrawn
Location
University of Iowa Hospitals and Clinics
Start Date
2009-06
Trial ID
NCT01048086
Treatments Being Tested
Octreotide capsule is a novel, orally-administered formulation of the comme...
Status
Unknown
Location
Keck Medical Center of University of Southern California
Start Date
2017-09-01
Trial ID
NCT03252353
Treatments Being Tested
The purpose of this study is to evaluate the safety and tolerability of tel...
Status
Completed
Location
Hematology Oncology Services of Arkansas
Start Date
2009-03
Trial ID
NCT00853047
Treatments Being Tested
Octreotide capsule is a novel, orally-administered formulation of the comme...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2016-02
Trial ID
NCT02685709
Treatments Being Tested
The objective of this study is to ascertain the safety, tolerability and pe...
Status
Completed
Location
Nucleus Network
Start Date
2019-07-09
Trial ID
NCT03798912
Treatments Being Tested
MYCAPSSA™ (formerly Octreolin™) is a proprietary oral form of the approved ...
Status
Completed
Location
Cedars-Sinai Medical Center
Start Date
2012-03
Trial ID
NCT01412424
Treatments Being Tested
A Phase 2 double-blind, placebo-controlled, randomized withdrawal study is ...
Status
Completed
Location
Ohio State University
Start Date
2019-03-11
Trial ID
NCT03792555
Treatments Being Tested